Teladoc Health price to sales ratio TDOC

Market value divided by revenue over the last twelve months, since 2016.

Today, Oct 23, 2026: 0.5×
10-year median: 7.7×
Against its 10-year history: 5th; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.3× to 49.1×
Peer median: 1.4×

Teladoc Health's price to sales ratio is 0.5× as of Oct 23, 2026.

That is below its ten-year median of 7.7×, lower than on 95% of days in the last ten years.

Over that time it ranged from 0.3× in Feb 2026 to 49.1× in Feb 2021.

The median for 10 hospital and care facility stocks of a similar size is 1.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	0.5×	0.3×	0.7×
2025	0.5×	0.5×	1.0×
2024	0.6×	0.5×	1.4×
2023	1.4×	1.0×	2.2×
2022	1.6×	1.6×	7.1×
2021	7.9×	7.9×	49.1×
2020	33.4×	11.6×	34.8×
2019	11.6×	8.2×	13.1×
2018	9.1×	8.3×	18.2×
2017	10.3×	7.0×	14.1×
2016	7.0×	4.3×	9.1×

Against its peers

Companies in Medical - Care Facilities nearest Teladoc Health's size, closest first, today.

Company	Price to sales ratio
TDOCTeladoc Health	0.5×
OMDAOmada Health	3.7×
USPHU S Physical Therapy	1.6×
PNTGPennant	1.3×
ARDTArdent Health	0.3×
HCSGHealthcare Services	0.9×
PGNYProgyny	1.7×
ADUSAddus HomeCare	1.5×
MDPediatrix Medical	1.2×
SBCSBC Medical	3.1×
PRVAPrivia Health	1.2×
Peer median	1.4×

Where Teladoc Health ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Teladoc Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.